{"id":202802,"url":"https://lda.senate.gov/api/v1/clients/202802/?format=json","client_id":12,"name":"AKEBIA THERAPEUTICS, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-07-01","registrant":{"id":401104833,"url":"https://lda.senate.gov/api/v1/registrants/401104833/?format=json","house_registrant_id":44133,"name":"AKEBIA THERAPEUTICS, INC.","description":"biopharmaceutical company","address_1":"245 First Street","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Cambridge","state":"MA","state_display":"Massachusetts","zip":"02142","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SARA FROELICH","contact_telephone":"+1 857-998-7068","dt_updated":"2026-01-30T13:18:06.546537-05:00"}}